Tardive Dystonia Related with Aripiprazole
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Tardive dystonia is characterized by sustained, generally slow involuntary twisting movements. It is estimated to occur at a frequency of 1% to 4% among patients who are taking an antipsychotic agent. Unlike the first generation antipsychotics, the second generation antipsychotics are less likely to cause neuroleptic-induced movement disorder. For aripiprazole, only a few cases have been reported for tardive dystonia. We present a young male, who developed a severe tardive dystonia after taking aripiprazole for 5 years. The patient was admitted to for the treatment of both hisdystonic and psychotic symptoms. Olanzapine was administered instead of aripiprazole and while his psychotic symptoms improved, the dystonic symptoms were continued. Therefore, olanzapine was switched to clozapine while augmenting with benzodiazepine, anti-cholinergic, and ginko biloba to control his tardive dystonia. After 2 weeks of treatment, the dystonic movement decreased remarkably.
Abstract
Tardive dystonia is characterized by sustained, generally slow involuntary twisting movements. It is estimated to occur at a frequency of 1% to 4% among patients who are taking an antipsychotic agent. Unlike the first generation antipsychotics, the second generation antipsychotics are less likely to cause neuroleptic-induced movement disorder. For aripiprazole, only a few cases have been reported for tardive dystonia. We present a young male, who developed a severe tardive dystonia after taking aripiprazole for 5 years. The patient was admitted to for the treatment of both hisdystonic and psychotic symptoms. Olanzapine was administered instead of aripiprazole and while his psychotic symptoms improved, the dystonic symptoms were continued. Therefore, olanzapine was switched to clozapine while augmenting with benzodiazepine, anti-cholinergic, and ginko biloba to control his tardive dystonia. After 2 weeks of treatment, the dystonic movement decreased remarkably.
참고문헌 (28)
- Tarsy D, "Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs", Handb Clin Neurol, 100, pp.601~616 (2011)
- Adityanjee, "The current status of tardive dystonia", Biol Psychiatry, 45, pp.715~730 (1999)
- Ryu S, "Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics : a cross-sectional and retrospective study", J Clin Psychopharmacol, 35, pp.13~21 (2015)
- Khouzam HR, "Identification and management of tardive dyskinesia : a case series and literature review", Postgrad Med, 127, pp.726~737 (2015)
- Wojcik JD, "A review of 32 cases of tardive dystonia", Am J Psychiatry, 148, pp.1055~1059 (1991)
- Burke RE, "Tardive dystonia : late-onset and persistent dystonia caused by antipsychotic drugs", Neurology, 32, pp.1335~1346 (1982)
- Shapiro DA, "Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology", Neuropsychopharmacology, 28, pp.1400~1411 (2003)
- Maytal G, "Aripiprazole-related tardive dyskinesia", CNS Spectr, 11, pp.435~439 (2006)
- Schwartz T, "Aripiprazole(abilify)and tardive dyskinesia", P T, 33, pp.32~34 (2008)
- Rakesh Goyal, "A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow Up", Clinical Psychopharmacology and Neuroscience, 12(1), pp.69~71 (2014), 대한정신약물학회
- Pinninti NR, "Tardive dystonia-associated prescription of aripiprazole", J Neuropsychiatry Clin Neurosci, 18, pp.426~427 (2006)
- Lim HK, "Tardive dystonic symptoms associated with aripiprazole treatment", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.589~590 (2008)
- Friedman JH, "Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient", J Clin Psychiatry, 71, pp.652~653 (2010)
- Matsuda N, "Tardive laryngeal dystonia associated with aripiprazole monotherapy", J Clin Psychopharmacol, 32, pp.297~298 (2012)
- Cha DS, "Treatment-emergent adverse events associated with atypical antipsychotics", Expert Opin Pharmacother, 13, pp.1587~1598 (2012)
- Gao K, "Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics", J Clin Psychiatry, 72, pp.1063~1071 (2011)
- Trugman JM, "Treatment of severe axial tardive dystonia with clozapine : case report and hypothesis", Mov Disord, 9, pp.441~446 (1994)
- Sachdev PS, "Neuroleptic-induced movement disorders: an overview", Psychiatr Clin North Am, 28, pp.255~274 (2005)
- van Harten PN, "Tardive dystonia", Schizophr Bull, 25, pp.741~748 (1999)
- Kato K, "Case of tardive dystonia improved by aripiprazole", Psychiatry Clin Neurosci, 64, pp.337~338 (2010)
- Takagai S, "Improvement in intractable tardive dystonia in bipolar disorder after aripiprazole treatment : a case report", J Clin Psychopharmacol, 32, pp.563~564 (2012)
- Grant MJ, "Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole", Ann Pharmacother, 39, pp.1953~ (2005)
- Kantrowitz JT, "Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot", J Clin Psychopharmacol, 27, pp.525~526 (2007)
- Lako IM, "Estimating dopamine D2 receptor occupancy for doses of 8 antipsychotics : a meta-analysis", J Clin Psychopharmacol, 33, pp.675~681 (2013)
- Joe S, "Remission of irreversible aripiprazole-induced tardive dystonia with clozapine : a case report", BMC Psychiatry, 15, pp.253~ (2015)
- Bhidayasiri R, "Evidence-based guideline : treatment of tardive syndromes : report of the Guideline Development Subcommittee of the American Academy of Neurology", Neurology, 81, pp.463~469 (2013)
- Pappa S, "Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study", Clin Neuropharmacol, 33, pp.271~275 (2010)
- Angus S, "A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia", J Clin Psychopharmacol, 17, pp.88~91 (1997)